Gensaic

Cambridge, United States

Gensaic is a redosable genomic medications company that seeks to reimagine gene therapy.

$3.5M raised

Jan 2023

Grant

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Gensaic raised?

Gensaic has raised $3.5M in total funding. The most recent round was Grant. The last funding was announced in January 2023.

Who are Gensaic's investors?

Gensaic's investors include Cystic Fibrosis Foundation.

Where is Gensaic headquartered?

Gensaic is headquartered in Cambridge, United States.

What does Gensaic do?

Gensaic is a redosable genomic medications company that seeks to reimagine gene therapy.

What stage is Gensaic at?

Gensaic is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 9, 2023.

MLA

"Gensaic — Funding & Investors." VCBacked, January 9, 2023, https://www.vcbacked.co/company/gensaic. Accessed July 3, 2026.

APA

VCBacked. (2023). Gensaic — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/gensaic

Wikipedia (cite web)

{{cite web |title=Gensaic — Funding & Investors |url=https://www.vcbacked.co/company/gensaic |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 9, 2023.